ADVERTISEMENT

precision medicine

Overall Survival for Progressive Bladder Cancer Improved with Personalized Peptide Vaccination

12/01/2015

JCP Editors

A new immunotherapy may help to improve outcomes of patients with metastatic bladder cancer, according to the results of a Phase II study. Bladder cancer is one of the most common and deadly forms of cancer for men...

A new immunotherapy may help to improve outcomes of patients with metastatic bladder cancer, according to the results of a Phase II study. Bladder cancer is one of the most common and deadly forms of cancer for men...

A new...

12/01/2015

Journal of Clinical Pathways

Research in Review

‚ÄòBasket Study‚Äô Shows Treatment Response in Certain Patients with Advanced Lung Cancer

09/17/2015

Jolynn Tumolo

Citations: Hyman DM, Puzanov I, Subbiah V, et al. Vemurafenib in multiple nonmelanoma cancers with BRAF V600 mutations. New Engl J Med. 2015;373:726–736. More than one-third of patients with advanced lung...

Citations: Hyman DM, Puzanov I, Subbiah V, et al. Vemurafenib in multiple nonmelanoma cancers with BRAF V600 mutations. New Engl J Med. 2015;373:726–736. More than one-third of patients with advanced lung...

...

09/17/2015

Journal of Clinical Pathways

Featured Webinar

Implementing ERAS Protocols Throughout Patient Peri-Op Journey: Reductions in Complications

Advertisement

Advertisement

Advertisement

Upcoming Events

September 21 ⁠–⁠ September 22

AMP Europe

September 30 ⁠–⁠ October 2

October 1 ⁠–⁠ October 2

October 2 ⁠–⁠ October 5

October 5 ⁠–⁠ October 6

October 14 ⁠–⁠ October 16

October 16 ⁠–⁠ October 19

October 19 ⁠–⁠ October 20

October 26 ⁠–⁠ October 27

October 29 ⁠–⁠ November 2

See Full Calendar

Advertisement

Advertisement